{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:23:15Z","timestamp":1786123395941,"version":"build-2736575974"},"reference-count":31,"publisher":"The Endocrine Society","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Ectopic Cushing syndrome (ECS) is a severe paraneoplastic complication of neuroendocrine neoplasms (NENs), but its association with survival and clinically relevant outcomes remains insufficiently defined in matched real-world cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the association of code-defined Cushing syndrome compatible with ECS with OS and clinical outcomes in patients with NENs using a large propensity score-matched cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective cohort study with 1:1 propensity score matching.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Electronic medical records from TriNetX Global Collaborative Network, a federated database aggregating clinical data from international healthcare organizations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients<\/jats:title>\n                    <jats:p>Adult patients (\u226518 years) with NEN (n = 105 854), including 265 in the ECS-compatible cohort. After matching, 264 patients in the ECS-compatible cohort were compared with 264 patients without documented Cushing syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measures<\/jats:title>\n                    <jats:p>Primary outcome was OS. Secondary outcomes included hospitalization, emergency care use, severe infections, venous thromboembolism, metabolic complications, organ failure, and metastatic progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>ECS was associated with significantly reduced OS compared with non-ECS patients (8-year survival: 55.3% vs 71.2%; hazard ratio [HR] 1.848 [95% confidence interval 1.348-2.534]; P &amp;lt; .001). ECS patients had increased risks of hospitalization, severe infections, venous thromboembolism, and metabolic complications including hypertension, diabetes mellitus, and hypokalemia, as well as organ failure (kidney and liver failure). No significant increase in metastatic progression was observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ECS-compatible Cushing syndrome was associated with worse survival and substantially higher morbidity in patients with NENs, mainly reflected by hypercortisolism-related complications rather than tumor progression. Early recognition and treatment of hypercortisolism may be critical to improve outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgag294","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:04:20Z","timestamp":1784721860000},"source":"Crossref","is-referenced-by-count":1,"title":["Cushing syndrome is associated with worse survival and higher morbidity in neuroendocrine neoplasms"],"prefix":"10.1210","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2697-2020","authenticated-orcid":false,"given":"Max","family":"Kappenstein","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Clinic for Radiology and Nuclear Medicine, Goethe University Frankfurt, University Hospital , 60590 Frankfurt ,","place":["Germany"]},{"name":"University of Luebeck, Department of Hematology and Oncology, University Cancer Center Schleswig-Holstein (UCCSH) and University Hospital Schleswig-Holstein (UKSH), Campus Luebeck, 23538 Luebeck ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Franziska","family":"Hamm","sequence":"additional","affiliation":[{"name":"University of Luebeck, Department of Hematology and Oncology, University Cancer Center Schleswig-Holstein (UCCSH) and University Hospital Schleswig-Holstein (UKSH), Campus Luebeck, 23538 Luebeck ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie Magdalena","family":"Lehmler","sequence":"additional","affiliation":[{"name":"Medical Clinic 1, University Hospital Frankfurt, Goethe University Frankfurt , 60590 Frankfurt ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Koch","sequence":"additional","affiliation":[{"name":"Medical Clinic 1, University Hospital Frankfurt, Goethe University Frankfurt , 60590 Frankfurt ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Groener","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Clinic for Radiology and Nuclear Medicine, Goethe University Frankfurt, University Hospital , 60590 Frankfurt ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Bojunga","sequence":"additional","affiliation":[{"name":"Medical Clinic 1, University Hospital Frankfurt, Goethe University Frankfurt , 60590 Frankfurt ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas","family":"von Bubnoff","sequence":"additional","affiliation":[{"name":"University of Luebeck, Department of Hematology and Oncology, University Cancer Center Schleswig-Holstein (UCCSH) and University Hospital Schleswig-Holstein (UKSH), Campus Luebeck, 23538 Luebeck ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2665-1181","authenticated-orcid":false,"given":"Viktoria Florentine","family":"Koehler","sequence":"additional","affiliation":[{"name":"Medical Clinic 1, University Hospital Frankfurt, Goethe University Frankfurt , 60590 Frankfurt ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"2026080711023173800_dgag294-B1","first-page":"1019","article-title":"Epidemiology of neuroendocrine neoplasia worldwide: a review of the literature (2012-2022)","volume":"115","author":"Nwoguh","year":"2025","journal-title":"Neuroendocrinology"},{"issue":"4","key":"2026080711023173800_dgag294-B2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tem.2023.12.003","article-title":"A clinical perspective on ectopic Cushing's syndrome","volume":"35","author":"Ragnarsson","year":"2024","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"2026080711023173800_dgag294-B3","doi-asserted-by":"crossref","first-page":"e121S","DOI":"10.1378\/chest.12-2352","article-title":"Clinical and organizational factors in the initial evaluation of patients with lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Ost","year":"2013","journal-title":"Chest"},{"issue":"3","key":"2026080711023173800_dgag294-B4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1530\/EJE-15-0968","article-title":"Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors","volume":"174","author":"Kamp","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"10418","key":"2026080711023173800_dgag294-B5","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/S0140-6736(23)01961-X","article-title":"Cushing's syndrome","volume":"402","author":"Gadelha","year":"2023","journal-title":"Lancet"},{"issue":"5","key":"2026080711023173800_dgag294-B6","doi-asserted-by":"crossref","first-page":"e2035","DOI":"10.1210\/clinem\/dgab058","article-title":"Acute and life-threatening complications in Cushing syndrome: prevalence, predictors, and mortality","volume":"106","author":"Schernthaner-Reiter","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026080711023173800_dgag294-B7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/cen.14617","article-title":"Medullary thyroid cancer with ectopic Cushing's syndrome: a multicentre case series","volume":"96","author":"Koehler","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2026080711023173800_dgag294-B8","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1093\/ejendo\/lvaf114","article-title":"Survival probabilities in patients with ectopic Cushing's syndrome-a systematic review and a single-arm meta-analysis","volume":"192","author":"Piasecka","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2026080711023173800_dgag294-B9","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13336","article-title":"ACTH-secreting pancreatic neuroendocrine neoplasms: a case-series","volume":"35","author":"Al-Toubah","year":"2023","journal-title":"J Neuroendocrinol"},{"issue":"4","key":"2026080711023173800_dgag294-B10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/EJE-16-0809","article-title":"Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study","volume":"176","author":"Davi\u2019","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026080711023173800_dgag294-B11","article-title":"Delayed diagnosis of ectopic Cushing syndrome","volume":"2","author":"Matson","year":"2024","journal-title":"JCEM Case Rep"},{"issue":"3","key":"2026080711023173800_dgag294-B12","doi-asserted-by":"crossref","first-page":"e901","DOI":"10.1210\/clinem\/dgad453","article-title":"Long-term consequences of Cushing syndrome: a systematic literature review","volume":"109","author":"Puglisi","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026080711023173800_dgag294-B13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1516126","article-title":"A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX","volume":"16","author":"Ludwig","year":"2025","journal-title":"Front Pharmacol"},{"issue":"6","key":"2026080711023173800_dgag294-B14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/10507256261442836","article-title":"Real-world efficacy and safety of lenvatinib and sorafenib in thyroid cancer: a retrospective, propensity-score-matched study","volume":"36","author":"Kappenstein","year":"2026","journal-title":"Thyroid"},{"key":"2026080711023173800_dgag294-B15","doi-asserted-by":"crossref","unstructured":"Kappenstein M, Hamm AF, Lehmler E, et al \u00a02026. Supplemental data from Kappenstein et al., Cushing syndrome is associated with worse survival and higher morbidity in neuroendocrine neoplasms. Figshare. 10.6084\/m9.figshare.32984144.","DOI":"10.1210\/clinem\/dgag294"},{"issue":"2","key":"2026080711023173800_dgag294-B16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s12020-018-1773-3","article-title":"Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms","volume":"64","author":"Daskalakis","year":"2019","journal-title":"Endocrine"},{"issue":"2","key":"2026080711023173800_dgag294-B17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/a-2799-7997","article-title":"The clinical spectrum and management of ectopic Cushing's syndrome: a 12-year single-center experience","volume":"134","author":"Kraljevic","year":"2026","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"2","key":"2026080711023173800_dgag294-B18","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae194","article-title":"Recognition and management of ectopic ACTH secreting tumors","volume":"9","author":"Elenius","year":"2025","journal-title":"J Endocr Soc"},{"issue":"3","key":"2026080711023173800_dgag294-B19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/endrev\/bnaf042","article-title":"Update and practical recommendations for the use of medical treatment of Cushing\u00b4s syndrome","volume":"47","author":"Araujo-Castro","year":"2026","journal-title":"Endocr Rev"},{"issue":"4","key":"2026080711023173800_dgag294-B20","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaf027","article-title":"Osilodrostat treatment for adrenal and ectopic Cushing syndrome: integration of clinical studies with case presentations","volume":"9","author":"Fleseriu","year":"2025","journal-title":"J Endocr Soc"},{"issue":"8","key":"2026080711023173800_dgag294-B21","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13318","article-title":"European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes","volume":"35","author":"Hofland","year":"2023","journal-title":"J Neuroendocrinol"},{"issue":"11","key":"2026080711023173800_dgag294-B22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242679","article-title":"Ectopic ACTH syndrome of different origin-diagnostic approach and clinical outcome. Experience of one clinical centre","volume":"15","author":"Pale\u0144-Tytko","year":"2020","journal-title":"PLoS One"},{"issue":"9","key":"2026080711023173800_dgag294-B23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.tem.2020.04.004","article-title":"The immune system in Cushing's syndrome","volume":"31","author":"Hasenmajer","year":"2020","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"2026080711023173800_dgag294-B24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s11102-022-01261-9","article-title":"Hypercoagulability in Cushing's syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols","volume":"25","author":"Feelders","year":"2022","journal-title":"Pituitary"},{"issue":"12","key":"2026080711023173800_dgag294-B25","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2026080711023173800_dgag294-B26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2002.tb04419.x","article-title":"Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases","volume":"970","author":"Torpy","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"2026080711023173800_dgag294-B27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jama.2023.11305","article-title":"Cushing syndrome: a review","volume":"330","author":"Reincke","year":"2023","journal-title":"JAMA"},{"issue":"12","key":"2026080711023173800_dgag294-B28","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jamasurg.2020.3280","article-title":"Evaluation and treatment of patients with hypercortisolism: a review","volume":"155","author":"Miller","year":"2020","journal-title":"JAMA Surg"},{"issue":"7","key":"2026080711023173800_dgag294-B29","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071649","article-title":"Prognostic significance of glucocorticoid receptor expression in cancer: a systematic review and meta-analysis","volume":"13","author":"Bakour","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026080711023173800_dgag294-B30","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1161768","article-title":"Glucocorticoid regulation of cancer development and progression","volume":"14","author":"Khadka","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2026080711023173800_dgag294-B31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.surg.2022.03.014","article-title":"Management of adrenocorticotropic hormone-secreting neuroendocrine tumors and the role of bilateral adrenalectomy in ectopic Cushing syndrome","volume":"172","author":"Landry","year":"2022","journal-title":"Surgery"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag294\/69857834\/dgag294.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag294\/69857834\/dgag294.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:02:40Z","timestamp":1786114960000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article\/doi\/10.1210\/clinem\/dgag294\/8740374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":31,"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag294","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"article-number":"dgag294"}}